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Background: Lineage specific differentiation of human embryonic stem cells (hESCs) is largely mediated by specific
growth factors and extracellular matrix molecules. Growth factors initiate a cascade of signals which control gene
transcription and cell fate specification. There is a lot of interest in inducing hESCs to an endoderm fate which
serves as a pathway towards more functional cell types like the pancreatic cells. Research over the past decade has
established several robust pathways for deriving endoderm from hESCs, with the capability of further maturation.
However, in our experience, the functional maturity of these endoderm derivatives, specifically to pancreatic
lineage, largely depends on specific pathway of endoderm induction. Hence it will be of interest to understand the
underlying mechanism mediating such induction and how it is translated to further maturation. In this work we
analyze the regulatory interactions mediating different pathways of endoderm induction by identifying
co-regulated transcription factors.
Results: hESCs were induced towards endoderm using activin A and 4 different growth factors (FGF2 (F), BMP4 (B),
PI3KI (P), and WNT3A (W)) and their combinations thereof, resulting in 15 total experimental conditions. At the end
of differentiation each condition was analyzed by qRT-PCR for 12 relevant endoderm related transcription factors
(TFs). As a first approach, we used hierarchical clustering to identify which growth factor combinations favor
up-regulation of different genes. In the next step we identified sets of co-regulated transcription factors using a
biclustering algorithm. The high variability of experimental data was addressed by integrating the biclustering
formulation with bootstrap re-sampling to identify robust networks of co-regulated transcription factors. Our results
show that the transition from early to late endoderm is favored by FGF2 as well as WNT3A treatments under high
activin. However, induction of late endoderm markers is relatively favored by WNT3A under high activin.
Conclusions: Use of FGF2, WNT3A or PI3K inhibition with high activin A may serve well in definitive endoderm
induction followed by WNT3A specific signaling to direct the definitive endoderm into late endodermal lineages.
Other combinations, though still feasible for endoderm induction, appear less promising for pancreatic endoderm
specification in our experiments.
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Embryonic stem cells have been shown to have tremen-
dous impact in the field of regenerative medicine be-
cause of its potential to differentiate to multiple cell
types of interest. Efficient harvesting of this potential
requires careful development of protocols to evolve the
cells through specific signaling pathways which will in-
duce desired lineages and properties in the differentiated
phenotypes. Our primary interest lies in differentiation
of human embryonic stem cells (hESCs) to insulin pro-
ducing β-cells of the pancreas as a cellular transplant-
ation strategy for diabetes mellitus. The first and
perhaps the most important step in differentiation to
endodermal organs like pancreas and liver is the com-
mitment to definitive endoderm (DE) [1]. Multiple sig-
naling pathways have been reported to have success in
inducing endoderm differentiation with subsequent mat-
uration to liver, pancreas and lung. While there is some
understanding of the activity pathway of these individual
signaling molecules, detailed knowledge of transcrip-
tional controls activated through these signaling path-
ways is largely unknown. Moreover, cooperative effect of
these endoderm induction pathways, along with its im-
pact on long term maturation has received less attention.
Although standard protocols have been established for
the later stages of pancreatic induction, it is not always
obvious how these endoderm derivatives derived from
different pathways will respond to subsequent pancreatic
induction signals. In this article, we have analyzed the
endoderm induction stage of the differentiation process
induced by the combinatorial action of the signaling
pathways using an integrated experimental and mathem-
atical approach. A detailed mathematical analysis is adopted
to capture co-regulated TFs across different growth factor
combinations and projection of maturation potential of the
various endoderm derivatives.
Differentiation of hESCs to DE
Activin A (henceforth denoted as activin) has been
shown to be effective in inducing DE from hESCs and is
a key induction factor used in many protocols [2,3].
However, recent studies have shown that activin alone
may not produce homogeneous differentiation and add-
itional factors must be used to modulate supplementary
signaling pathways along with the nodal pathway acti-
vated by activin [1,4]. We chose several widely used DE
induction protocols all of which involve activin with
either PI3K inhibition [5], WNT3A [3], BMP4 [6] or
FGF2 [7]. The hESCs were differentiated into DE using
these molecules alone and in all possible combinations,
at the end of which the differentiated cell population
was analyzed for endoderm markers. Our aim is twofold:
to identify which growth factor combinations are most
effective for efficient DE induction; and to understandTF interactions governing these induction conditions.
We analyzed the mean expression data using Hierarch-
ical clustering (HC) to identify relationships between the
conditions and the TFs and biclustering on the original
expression data with replicates to identify the TFs which
are co-regulated under subsets of these conditions.
Hierarchical clustering
HC is a useful technique to analyze and interpret multivari-
ate data. Each data point here is represented as a vector
and the distances between these data points are measured
using a suitable distance measure [8]. The clustering
process then links the data points together and the result is
a hierarchical grouping of the data points in each of the
dimensions (TFs and conditions in our case). Our primary
goal in using HC is to capture the similarities between
different growth factor treatments for DE induction as well
as to identify co-regulated TFs under each of these treat-
ments. HC has been successfully used in a number of
bioinformatics applications including microarray data ana-
lysis, structure identification of bio-molecules and gene
pathway identification [9].
Biclustering to identify co-regulated genes across
different conditions
While HC homogenizes the entire dataset, techniques like
biclustering are useful in preserving the second dimension
in clustering; in our case all the endoderm induction con-
ditions. We are interested in identifying specific sets of
genes exhibiting similar expression patterns across various
subsets of experimental conditions, which can be achieved
by biclustering. Likewise, many TFs are known to have
multiple functions, and hence participate in multiple regu-
latory networks, which can also be captured by overlapped
biclusters [10]. In 2000, Cheng and Church proposed the
use of a similarity measure called the mean square residue
for identification of coherent biclusters [11]. Since then
newer and better algorithms have been developed to iden-
tify biclusters with particular characteristic trends like
coherence, low overlaps and hierarchical structure [12].
These algorithms perform either one or a combination of
iterative row and column clustering, greedy iterative
search, exhaustive bicluster enumeration or distribution
parameter identification [13]. Bleuler et al. proposed an
evolutionary algorithm (EA) to determine high quality, par-
tially overlapped biclusters using the Cheng and Church
formulation [14]. EAs have the advantage of large search
space and are efficient methods for complex optimization
problems [15]. High quality biclusters should satisfy many
criteria; namely they should contain as many genes and
conditions as possible, low mean square residue, high row
variance and should have low overlapping. Divina et al.
formulated Sequential Evolutionary Biclustering (SEBI)
algorithm to identify such biclusters from the expression
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tify important biclusters for the endoderm induction data
under different combinations of the growth factors [15].
SEBI can find high quality biclusters and has been proved
to perform well for large-scale biological datasets [15]. At
the same time, it allows the user the flexibility of selecting
the degree of overlap of the biclusters.
Handling data variability
The gene expression data obtained for cell culture sys-
tems are subjected to noise because of the heterogeneity
and stochasticity associated with the system. Differences
among the biological replicates may therefore arise due
to the inherent heterogeneity of the ES cell population
as well as by experimental noise [16]. Therefore, it is es-
sential that the biclustering algorithm be supplemented
with additional methods to discover good quality and
robust biclusters from noisy gene expression data. One
way to do this is to obtain a large number of experimen-
tal replicates and perform biclustering over the entire
dataset. This is however, expensive and impractical. A
mathematical surrogate of this approach is bootstrap-
ping, a concept first presented systematically by Efron
et al. [17].
Essentially, bootstrapping generates a pseudo dataset
from the small number of experimental replicates by a
sampling with replacement technique. The advantage of
bootstrap lies in estimating statistically significant para-
meters from a limited number of experimental replicates
[18]. Thus, the results from a bootstrap analysis can pro-
vide information on the parameter variances and confi-
dence intervals. These bootstrap data-sets are further
analyzed by ensemble methods like bagging to identify
aggregation of biclusters, referred to as meta-clustersqRT-PCR data
(in replicates)
Bootstrap
pseudo-datasets
1
2
3
Figure 1 Work-flow for the entire analysis from data collection to ide
data and perform bootstrap with re-sampling to obtain 1000 pseudo-datas
obtain the most coherent pattern in each dataset. The resulting biclusters a[19]. We have adopted a similar approach to aggregate
the individual biclusters identified from the bootstrap
datasets. However instead of identifying an ensemble of
biclusters, we have concentrated on identifying the most
repeated subset of the bicluster, which we denote as
robust.
Results
The focus of this work is to understand the mechanism
of endoderm induction using different growth factors,
acting alone and in combination, from an integrated
experimental and computational approach (summarized
in Figure 1). The H1 human embryonic stem cells were
induced towards endoderm lineage using activin along
with alternate growth factors, namely FGF2, BMP4,
PI3KI, WNT3A, added in 15 combinations. The cells
differentiated thereof were analyzed in detail for their
gene expression levels, specifically concentrating on a
broad range of endoderm markers along with represen-
tative pancreatic endoderm markers.
Experimental analysis of endoderm differentiation using
combinations of major pathways
Figure 2a shows the mean expression data plotted as
fold changes in 12 genes across the 15 experimental con-
ditions. At this stage, the fold change data showed inter-
esting trends for the different conditions. When using
only one factor other than activin, PI3KI along with acti-
vin was found to give the highest expression of most of
the DE markers while BMP4 and activin in combination
was found to give the lowest expression among the four
conditions. Interestingly, BMP4 was found to perform
better in combination with another factor like WNT3A
or FGF2. Also, FGF2 containing conditions were foundBiclusters
Most repeated bicluster 
subsets
ntification of robust biclusters. In short, we start with the qRT-PCR
ets. Each of these datasets is subjected to biclustering analysis to
re then analyzed for the most repeated subsets of biclusters.
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Figure 2 Fold change data for the 12 transcriptional markers across 15 experimental conditions. (a) The fold change calculated from the
mean expression data from qRT-PCR on day 4 of the differentiation process is plotted from the expression matrix, X, constructed using rows as
the TFs and columns as the experimental conditions. (b) Variation observed in the 12 transcriptional markers with changes in the signaling
pathways presented as mean ± SE. All the major DE markers CER, CXCR4, FOXA2, SOX17 and the later endoderm markers HNF4α, HNF1β and
GATA4 show significant changes with the nature of DE induction.
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HNF4α. Among the 4 conditions which contain 3 factors
other than activin, combinations of FGF2, BMP4 and
PI3KI perform well. Using all the factors together was
not particularly useful since all the TFs maintained
expressions in the same range as other combinations.
Figure 2b shows the range of variation observed in each
of the transcriptional markers across the 15 experimen-
tal conditions along-with the experimental replicates.
The levels of DE markers CER, FOXA2, CXCR4 and late
endoderm markers HNF4α, HNF1β and GATA4 change
substantially when the induction conditions are changed.
This level of analysis, however, makes it difficult to draw
mechanistic insights from the dataset. Hence, we per-
formed a more rigorous mathematical analysis to separate
out the TF trends and associate them with the appropriate
conditions. Because of the inherent differences in expres-
sion level of different genes, it is essential to normalize
the data to avoid bias. For the mathematical analysis, the
data presented in Figure 2a was normalized by mean cen-
tering and variance scaling so that every TF has a mean
expression value of zero and standard deviation of one.Hierarchical clustering of the mean expression data
identifies differences in the endoderm induced by BMP4
in the presence and absence of exogenous FGF2
The mean experimental data matrix was first analyzed
using hierarchical clustering which clusters the TFs and
conditions separately, as shown in Figure 3. Among the
conditions, two major branches were observed: the first
cluster contains BMP4 dominant conditions (B, B + W,
B + P, B + W + P) and the second cluster contains the
remaining conditions which also includes BMP4 but
interestingly only in combination with FGF2. The TFs
also segregate into two branches; the first branch con-
tains the late endoderm markers and one of the DE mar-
kers (HNF4α, HNF1β, GATA4, PDX1, FOXA2), the
second branch contains the early DE and late endoderm
markers (OCT4, BRACHYURY, CER, HNF6, CXCR4,
SOX17, PTF1α). The first group of markers is particu-
larly high in BMP4 dominant conditions and low in the
other conditions. The second group of markers is low in
the BMP4 dominant conditions and high in the presence
of PI3KI, WNT3A and BMP4 and high FGF2. Thus our
results point to differences in activin and BMP4 induced
BMP4, 
endo FGF2
WNT3A, PI3KI, 
BMP4, exo FGF2 
Late 
Endoderm
Early 
Endoderm
12
Figure 3 Hierarchical clustering on the mean expression data. The conditions cluster into two major groups, one containing BMP4 in the
absence of exogenous FGF2 and the other containing all the other treatments and BMP4 in combination with exogenous FGF2. Activin A is
common among all the treatments. The TFs cluster into two groups, the late and early endoderm markers.
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FGF2. We performed principal component analysis (PCA)
on the same data retaining only the first three components
to filter noise and identify the most represented groups.
As shown in the Additional file 1, a similar conclusion
can be drawn from PCA further supporting our analysis.
The clusters identified by the hierarchical algorithm
reflect our biological understanding of the induction
conditions as seen from the previous studies. A major
difference between the two clusters of conditions was
the context dependent function of BMP4. In the pres-
ence of FGF2 and high activin, BMP4 was found to favor
the endodermal lineage which was seen in several recent
studies [20-22] and was also on par with PI3KI domin-
ant conditions which gave the best endoderm in our
experiments. Also, in our BMP4 dominant conditions,
the late stage markers showed very high expression
while the major DE markers were low indicating that the
resulting endoderm may already be mature. Among the
second group of conditions, PI3KI and high activin
resulted in high expression of three major DE markers
SOX17, CXCR4 and CER which is supported by a num-
ber of earlier studies [23,24]. Using all the factors
together does not improve upon the endoderm derived
by PI3KI treatment. The second group of conditions also
contains FGF2 as a major factor along with WNT3A. It
is found that both pluripotency (OCT4) and theendoderm factors (CER and HNF6) are relatively favored
by conditions involving FGF2 and WNT3A as the major
contributor. In fact, FGF2 has been found to be suffi-
cient to maintain the hESCs in the pluripotent state [25]
and has also been used for endoderm induction in
several differentiation protocols [26]. Thus, FGF2 can
potentially favor both pluripotency as well as endoderm
differentiation depending on associated conditions.
Identification of co-regulated transcription factors by
biclustering
While hierarchical clustering enables a fast and simplis-
tic analysis of the experimental data sets, it does not
provide information on which subsets of TFs are co-
regulated across subsets of conditions. Identifying such
co-clusters will be beneficial, since the governing signal-
ing pathways change with the induction condition and
the same TFs may not be co-regulated. The technique of
biclustering serves to mine subgroups of such TFs exhi-
biting similar trends in their expression level under sub-
sets of conditions. Hence TFs appearing in the same
bicluster can be inferred to be co-regulated and constitu-
ents of a similar network architecture. The experimental
data matrix, X, constituting the mean expression data
across all the growth factor conditions is analyzed using
the algorithm elaborated in Methods section. Here, the
biclustering approach is formulated as an optimization
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quality of every candidate bicluster is assessed by a fit-
ness function. The fitness function has a number of free
parameters associated with it which can be tuned in
order to identify certain desired trends. The detailed pro-
cedure on the selection of the optimum parameters is
outlined in the Additional file 2.
The developed optimization based bicluster identifica-
tion algorithm was applied to the mean expression data
with the above mentioned parameters, which resulted in
a 3-gene 5-condition bicluster as illustrated in Figure 4
(a). However, to identify additional biclusters, possibly
with overlaps, the SEBI algorithm was subsequently run
by penalizing the identified biclusters. One such biclus-
ter is presented in Figure 4 (b). Although, the SEBI algo-
rithm allows some degree of overlapping amongst the
subsequent biclusters, the current mean dataset did not
result in any overlaps.
Recently, a new method was proposed by Banka et al.
called as Fuzzy Possibilistic Biclustering which assigns a
membership value to each gene-condition pair in the
expression matrix and therefore, allows varying degree(b)
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Figure 4 Biclusters obtained from the normalized mean expression d
conditions. (b) Subsequent bicluster containing 3 genes and 7 conditionsof overlapping amongst the biclusters [27,28]. However,
though the method has been proven to provide very
large biclusters with acceptable residue, the selection of
the degree of fuzziness often depends upon the question
that the biologists have set to answer [29]. In our case,
we are interested in analyzing the well identified markers
of endoderm induction under necessary signaling path-
ways. Since, our aim is to discover subtle differences in
the gene regulation when the induction conditions are
changed, a traditional crisp method like SEBI will be
more useful for identifying the best induction condition.
Robust biclusters identify WNT3A treatment to favor both
early and late endoderm
The above identified biclusters were for the mean data-
set, and hence does not explicitly take into account the
experimental variations. In general biological datasets are
known for their noise and uncertainty, and in particular
stem cells have inherent heterogeneity and stochasticity.
In order to increase confidence in the identified bicluster
we undertook bootstrap analysis on the experimental
data to generate 1000 pseudo-datasets. Each of theseF+P B+W B+W+P
GATA4
HNF1β
HNF4α
B+P W+P F+B+W B+W+P
PTF1α
CER
HNF6
ata. (a) Optimal Bicluster The bicluster contains 3 genes across 5
. The bicluster parameters selected were δ = 1.5, Wc, Wr = 1.
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subjected to the entire biclustering analysis. In order to
identify somewhat overlapped biclusters, we ran the
biclustering algorithm five times at each data point by
subsequently penalizing previously identified biclusters.
The next task was to determine a robust bicluster
from this array of alternate biclusters. We hypothesize
that the robust bicluster will not be significantly affected
by the experimental noise, and hence will appear a large
number of times in the bootstrapped-bicluster data set.
However, a thorough search of the entire array of alter-
nate biclusters for frequency of repeats did not yield any
satisfactory outcome. Thus we could not find a single
bicluster that was significantly repeated in its entirety
across the data set. Instead, we realized subsets of genes
and conditions of the bicluster were being repeated with
very high frequency instead of the entire bicluster.
Hence, we focused on identifying such subsets from the
family of bootstrap + bicluster solutions. Setting a mini-
mum threshold of 50% repeats across the bootstrap sam-
ples, we identified 6 such subsets. First five of these
contained different combinations of the same two mar-
kers and four conditions. Hence we collected them to-
gether into a single group. The profiles of the repeated
subsets are presented in Figure 5. These subsets are of
two kinds: Group 1 contains (CER, HNF6 | F, F + W, B
+ W + P, B + P) and Group 2 contains (HNF6, HNF4α |
F + B, F + P, W + P). It is important to note that the
robust biclusters were different from the biclusters
obtained for the mean expression data. For example, the
biclusters in Figure 4 show that HNF4α clusters closer
to HNF1β (and GATA4) rather than CER. This is also
evident from our hierarchical clusters in Figure 3. The
fact that they do not appear together in the robust
biclusters is interesting and shows that analysis from
mean datasets can be risky for stem cell systems when
there is inherent variability among the replicates. Sup-
portively; the HNF4α, HNF1β (and GATA4) combination
occurs in subsets with less than 300 repeats (data not
shown).0.1
1
10
100
F B+P F+W B+W+P
2-(
CT
)
Conditions
Group 1 CER
HNF6
Figure 5 Robust subsets identified from the 1000 bootstrap datasets.
parameters selected were δ = 1.5, Wc, Wr = 1. Note: Group 1 contains five sFigure 6 shows a summary of the robust biclusters
represented as a bipartite graph of genes and conditions.
The identified biclusters are biologically relevant to the
development stages in vivo. Group 1 contains endoderm
markers CER and HNF6 under FGF2/WNT3A and
BMP4/WNT3A/PI3KI. CER is an important early mar-
ker for the DE stage rising after the formation of the
primitive streak during development while HNF6 is a
marker for a more primitive foregut stage in pancreas
development [2]. Thus, Group 1 is similar to the foregut
development stage in vivo [30]. In addition, the condi-
tions in Group 1 contain FGF2 and WNT3A but not
BMP4 and as seen from Figure 5, CER and HNF6
decrease under BMP4 dominance. Thus, the biclustering
analysis shows that the early marker CER and a late
endoderm marker HNF6 are controlled by the FGF2,
WNT3A pathway and are relatively down-regulated
under BMP4 and PI3KI. Group 2 contains another
primitive foregut stage marker HNF4α along-with HNF6
[2]. Interestingly here, the biclustering results show that
pancreatic endodermal transcriptional machinery may
not be favored at the DE stage by the FGF2 + BMP4
combination although in our hierarchical clustering
results FGF2 + BMP4 combination clustered with the
other conditions that gave a better DE signature. We
also note that WNT3A and PI3KI combination with
high activin increased the expression of HNF4α and
HNF6 and these conditions also gave a successful DE
signature as seen from the hierarchical clustering. Thus
our results indicate that WNT3A pathway can favor
both early and late markers like CER, HNF4α and HNF6.
Also, WNT3A + PI3KI induced DE cells may be more
capable of developing into later pancreatic lineages.
While WNT3A and PI3KI have been used for DE induc-
tion towards pancreatic maturation [3,5], the effect of
co-induction has not been explored yet.
Discussion
The differentiation of hESCs into the endoderm lineages
is carried out by the activation of different signaling0.1
1
10
100
F+B W+P F+P
2-
(
CT
)
Conditions
Group 2 HNF4α
HNF6
Robust biclusters are the most repeated subsets (>500). The bicluster
ubsets only one of which is shown.
Group 1
CER HNF6
F F+W B+W+P B+P
1 2 3 4 5
HNF4α HNF6
F+B F+P W+P
6
Group 2
Figure 6 Robust subsets of co-regulated genes presented as a bipartite graph.. We have identified high Activin along with PI3K inhibition
or activin in combination with WNT3A to work the best to co-regulate early endoderm marker CER and late endoderm markers HNF6. The Group
2 TFs HNF4α and HNF6 are part of the network inducing NGN3 and PDX1, reminiscent of the pancreatic genotype and are favored by high activin
with PI3KI and WNT3A.
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there is no consensus on which induction method is the
most desirable and whether combination of these could
result in an endoderm with the best signature. Here, we
have used a combination of experimental and mathemat-
ical techniques to shed light on these concerns.
The DE signature differs under exogenous activation of
different signaling pathways participating in endoderm
commitment
Our experiments with different DE inducing conditions
show that the DE potential of the differentiating hESCs
is highly dependent on the method of DE induction. The
major DE markers (CER, CXCR4, FOXA2, SOX17)
showed considerable variation when some of the path-
ways were activated above their basal levels.
All the pathways studied here have been known to be
important at the earlier stages of in vivo endoderm dif-
ferentiation and has also been documented as necessary
for in vitro differentiation [2,6,7,31]. The common de-
nominator in our studies is activin A which is an essen-
tial inducer of DE [2,3,24]. This is primarily because
activin, being a member of the TGFβ family, mimics
nodal signaling which is proven to be necessary for
endoderm development [4]. Activin has been shown to
maintain pluripotency at low concentrations and to
induce mesoderm and endoderm at high concentrations
[25]. However, activin alone may not result in efficient
endoderm induction [1]. Low PI3K signaling was essen-
tial for efficient induction of DE from hESCs [24]. Our
hierarchical clusters show that Activin and PI3K inhib-
ition in combination favor the up-regulation of a num-
ber of DE markers and form the most minimal signaling
pathways to be modulated for efficient DE induction. In
fact a number of recent studies have identified the inter-
play between PI3K/Akt and Activin/Smad2,3 pathways
and the resulting regulation of the gene transcription
events necessary for early DE induction [23].Among the DE markers, CER showed up-regulation
on differentiation, and the highest up-regulation was
achieved in the presence of FGF2, WNT and PI3KI
treatments. Katoh et al. recently identified the binding
domains of several key signaling effectors of the activin
and WNT pathways on the promoter regions of CER in
hESCs [32]. According to their results, the key nodal
effectors Smad3/Smad4 as well as the WNT effectors
beta-catenin and TCF/LEF transcriptional complex regu-
late the expression of the CER gene. In addition to high
activin and WNT signaling, PI3K inhibition may be
necessary to enhance the effect of nodal signaling as
Smad3/Smad4 complex is negatively regulated by Akt
[23]. Exogenous FGF2 simultaneously activates the ERK
pathway and maintains the expression of other key regu-
lators of differentiation [33]. However, BMP4 effectors
Smad1/3 may compete with the activin pathway and
thus reduce the up-regulation of CER, as substantiated
by the consistent grouping of the BMP4 dominant con-
ditions in the hierarchical clustering with low CER as a
common marker.
The response to the BMP4 pathway, however, was highly
dependent on the context, namely the presence and ab-
sence of FGF2 which was a striking feature of the hierarch-
ical clustering on the 15 conditions. BMP4 is typically
known as an activin antagonist and high concentrations of
BMP4 in the culture with high activin results in mesoderm
fate [34-36]. At the same time, BMP4 alone results in the
extra-embryonic lineages [37]. The presence of FGF2 with
BMP4 modulates the net response to the mesendoderm
fate, which is an intermediate stage that can result in DE
and mesoderm. Several recent studies have demonstrated
the use of this combination to promote endoderm forma-
tion [21,22,38]. FGF2 sustains the expression of Nanog
(a pluripotency marker) and this sustained Nanog expres-
sion is found to shift the outcome of BMP4 induced differ-
entiation of hESCs towards mesendoderm [22]. However,
prolonged use of FGF2 and BMP4 together may be
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bination has been shown to induce hepatic differentiation
after the DE stage [30]. Also, BMP4 dominant clusters
showed high expression of late endoderm markers HNF4α,
HNF1β and GATA4. This may indicate that BMP4 acceler-
ates the differentiation to the mesendoderm phase and
therefore, the overall dynamics may be faster for the BMP4
dominant case. But, it was striking to note that the expres-
sion of HNF6, another important marker for late endo-
derm was still lower in the BMP4 dominant case. Hence,
hierarchical clustering alone was not sufficient to answer if
BMP4 addition could be useful for late endoderm differen-
tiation. Importantly, BMP4 dominant conditions gave low
expression of markers from the robust biclusters. Thus the
current analysis shows that BMP4 may not be a suitable
choice for endoderm induction.
WNT3A/β-catenin signaling has been shown to be im-
portant both for maintenance of pluripotency as well as
induction of differentiation [25]. The WNT pathway is also
found to be important in the formation of primitive streak
due to which it is often used in the very early stages of
in vitro differentiation until the formation of mesendoderm
[2]. Stabilization of β-catenin by canonical WNT signaling
is found to be responsible for differentiation by epithelial-
mesenchymal transition;, however presence of Wnt after
this stage supports mesoderm [36]. Also, FGF2 is found to
synergistically influence the WNT pathway [39]. WNT
alongwith PI3KI was commonly present in both the groups
identified by our hierarchical clustering. WNT was consist-
ently found to be supportive to the activin + FGF2 signal-
ing assessed by the up-regulation of DE markers. Hence,
WNT and PI3KI may be the essential pathway modulators
necessary for endoderm differentiation.
Robust biclusters identify the necessary pathways for
efficient endoderm differentiation to the pancreatic
lineage
The robust biclusters identified by the biclustering +
bootstrap analysis show the most important trends pre-
served under experimental variations. Supportively, CER,
HNF6 and HNF4α belonged to the robust clusters. As
mentioned earlier, CER is an important target of the acti-
vin and WNT signaling pathways and HNF6 is a very
early pancreatic progenitor marker taking part in the
transcriptional network activating pancreatic progenitors
[32,40]. As seen from the Group 1 bicluster, FGF2 +
WNT3A conditions favor CER and HNF6 while BMP4
limits their up-regulation. It is also found that the stabil-
ity of β–catenin is partly enhanced by PI3K signaling
(activated by FGF2) [41] and hence this combination of
high activin + FGF2 + WNT3A may work to control the
expression of some endoderm markers like CER and
HNF6. At the same time, CER protein is a negative regu-
lator of the Tgfb (activin, BMP4) pathway and up-regulation of CER is necessary to limit the activation of
these pathways, since inhibition of the Tgfb pathway was
found to be necessary for efficient differentiation to the
pancreatic progenitors after PDX1 and HNF6 expression
[42]. However, external addition of WNT3A may still be
necessary since CER negatively regulates the WNT path-
way [32].
Alternatively, the markers HNF4α and HNF6 which
occur in Group 2 are co-regulated under FGF2 + BMP4,
FGF2 + WNT3A + PI3KI action. These markers also
occur in the MODY network for induction of Neuro-
genin expressing cells which represents mature pancre-
atic lineage [40]. HNF6 occupies a predominant position
in regulating the expression of HNF4α and other genes
prior to PDX1 induction. A key result identified by the
bicluster was the consistent up-regulation of the late
pancreatic markers HNF4α and HNF6 under WNT3A +
PI3KI dominant conditions and studies by Nostro et al.
have indicated the necessity of WNT3A for induction of
pancreatic progenitors [42]. CER, HNF6 combination
was also up-regulated under WNT3A conditions and
thus WNT3A addition was found to favor both DE mar-
kers as well as late pancreatic endoderm markers sup-
posedly showing similarity with in vivo pancreatic
organogenesis. The presence of FGF2 and BMP4 lowers
the expression of these markers and is consistent with
the inhibition of FGF2 and BMP4 at the later stages for
inhibition of a hepatic fate and efficient pancreatic
lineage selection [42]. The key signaling pathway interac-
tions from the robust biclusters are summarized in
Figure 7.
Conclusion
The focus of the current work was to achieve insights
into the in vitro differentiation process of human embry-
onic stem cells to the endoderm stage using both experi-
mental and mathematical approaches. Our work has
identified the differences between the different protocols
for endoderm induction. Essentially, high activin A and
PI3K inhibition or high activin A with FGF2 or WNT3A
serve well as early DE inducer. Additionally, biclustering
shows that the early and late endoderm markers are co-
regulated under high activin and WNT3A. Thus, overall
high activin with PI3KI and WNT3A together may serve
better for in vitro differentiation of hESCs to the defini-
tive endoderm and pancreatic endoderm lineages.
Methods
Experimental methods
Cell culture and treatment
hESC maintenance H1 hESCs were placed on hESC
certified matrigel coated wells and maintained with
mTeSR1 with media change every day. Cells were
CER
High Activin (+PI3KI)
High Activin (+PI3KI)
BMP4
WNT3A
HNF6
FGF2
GROUP 1
HNF4α
FGF2+BMP4
HNF6
GROUP 2
WNT3A
Early Endoderm Late Endoderm
Figure 7 Figure summarizing the functional dependence of the co-regulated genes on the active signaling pathways of endoderm
induction. CER and HNF6 are favoured by High activin and PI3KI, WNT3A, FGF2 while HNF4α and HNF6 are favoured by High activin, WNT3A and
PI3KI. Combining the early and late stages, high activin with PI3KI and WNT3A together is an effective strategy for endoderm differentiation.
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dispase for 5 minutes followed by mechanically breaking
the colonies and splitting at a 1:3–1:5 dilution. Cells
were examined under the microscope every day and
colonies with observable differentiation were picked and
removed before the media changes.hESC differentiation to DE H1 hESCs were allowed to
grow to 60-70% confluency before the experiments were
started. Once confluency was reached, differentiation
was performed by adding DE induction media for 4 days
with media change every day. Several induction condi-
tions were chosen according to previously published
studies [3,5-7]. All conditions were prepared in DMEM:
F12 supplemented with B27 and 0.2% BSA with 100
ng/ml Activin A. Conditions involved the use of individ-
ual and all possible combinations of growth factors and
molecules at the following concentrations: basic FGF (F)
at 100 ng/ml, BMP4 (B) at 100 ng/ml, WNT3A (W) at
25 ng/ml and Wortmannin (PI3K inhibitor, P) at 1 μM.
This leads to 15 different experimental conditions.Measurement of Transcription Factor (TF) expression
After 4 days of DE induction, cells were lysed and RNA
extracted using Nucleospin RNA II kit (Macherey Nagel)
according to the manufacturer’s instructions. The sample
absorbance at 280 nm and 260 nm was measured using a
BioRad Smart Spec spectrophotometer to obtain RNA
concentration and quality. Reverse transcription was per-
formed using ImProm II Promega reverse transcription
kit following the manufacturer’s recommendation. qRT-
PCR analysis was performed for endoderm and pancreatic
markers using the primers listed in Additional file 3:
Table S1.A total of 12 transcription factors were studied which
included pluripotency marker OCT4, mesendoderm
marker BRACHYURY, DE markers namely, CXCR4,
SOX17, CER, FOXA2 and pancreatic progenitor markers
PTF1α, PDX1, GATA4, HNF1β, HNF4α and HNF6.
GAPDH was selected as the housekeeping gene. Briefly,
the fold change was calculated from the cycle times, CT,
after normalization with respect to the control sample
and housekeeping gene, GAPDH as: 2ΔΔCT , where,
ΔΔCT = [(CT,target −CT,GAPDH)sample − (CT,target −CT,
GAPDH)undiff cells]. The control sample was chosen to be
undifferentiated cells at day 0.TF expression profiles
The TF expression profiles can be grouped together to
form an expression matrix with the rows corresponding
to the measurements of interest (like the relative mRNA
concentrations) and the columns corresponding to the
experimental conditions or samples. Thus, each element
in the matrix refers to the intensity of the particular
measurement in a given sample [43]. Many of the genes
are closely regulated under a subset of conditions indi-
cating that they are probably under the influence of the
same regulatory network under these conditions [12].
The expression data is helpful in identifying such sub
groups of transcription factors and conditions. However,
expression data matrices are often complex and further
computational analysis is required to mine important
connections from such large expression matrices.Mathematical analysis
Hierarchical clustering
Hierarchical clustering partitions the data into clusters
through an iterative process, where similarity or
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matrix is calculated using an appropriate distance measure
followed by grouping the variables in close proximity using
a linkage function. We used the in-built Matlab functions
to perform the analysis using various distance measures e.g.
Euclidean, city block etc., on the mean centered and vari-
ance scaled expression matrix. The results were represented
as a clustergram i.e. the linkage tree and the corresponding
heat map. We tested the tree generated using different link-
age measures after normalization of the mean expression
matrix and found all the trees to be very similar with the
cophenetic correlation coefficient greater than 0.9.Biclustering algorithm
Biclustering can be described as two dimensional clus-
tering, where a subset of genes exhibiting similar trend
across a subset of conditions is being identified. Such
subsets can be considered to be participating in similar
regulatory mechanism, hence constituting a regulatory
network. In order to identify sets of TFs expressing
coherent trends under specific sets of conditions, we
analyzed our TF-condition matrix, X, using the Sequen-
tial Evolutionary Biclustering (SEBI) developed by Divina
et al. [15]. The SEBI algorithm identifies coherent biclus-
ters sequentially with the help of a number of metrics as
described below. For a bicluster B(I, J) ∈ X, containing
elements, eij for i ∈ I, j ∈ J, the residue, rij of each element
in the bicluster is defined as: rij = eij − eiJ − eIj − eIJ. The
gene base is defined as eiJ ¼
X
j∈J
eij
Jj j , with I and J repre-
senting the total number of genes and conditions re-
spectively in the bicluster B. The condition base is
defined as eIj ¼
X
i∈I
eij
Ij j . The base of the bicluster is the
mean of all entries in the bicluster, i.e., eIJ ¼
X
i∈I;j∈J
eij
Ij j Jj j . The
residue, therefore, indicates the degree of coherence of
the element with other elements in the bicluster. Fur-
ther, the squared mean residue of all the elements in the
bicluster is defined as rIJ ¼
X
i∈I;j∈J
r2ij
Ij j Jj j . It is possible to have
biclusters having constant expression values and hence
have low residue value. To avoid such trivial biclusters,
the variance metric is introduced. The variance, varIJ, of
a bicluster is defined as, varIJ ¼
X
i∈I;j∈J
eij  eiJ
 2
ij
Ij j Jj j . Hence,
the variance captures fluctuating trends. Finally, we
would be interested in biclusters with as many genes
and conditions as possible i.e. having large volume. The
basic premise of the analysis is that the genes belongingto a bicluster are under the influence of a common regu-
latory pathway and hence show coherence in their
expression trends. However it is possible for the genes
to participate in multiple regulatory pathways, to capture
which we allow certain degree of overlapping amongst
the biclusters discovered sequentially by the SEBI algo-
rithm using a penalty term.
Thus, our final goal is to find biclusters of maximum
size, with mean squared residue lower than a given
threshold (δ), with relatively high row variance, and a
low level of overlapping among the biclusters. We repre-
sent this as an optimization problem with objective
function defined as [15]:
min
X
; F Bð Þ ¼ m residue Bð Þ
δ
þ 1
row variance Bð Þ þ wd
þ penalty
ð1Þ
In this function, B (I, J) is an individual solution,
m_residue is the mean squared residue of the bicluster
B, row_variance (B) is the row variance of B, penalty ¼
X
i∈I;j∈J
wp eij
 
, where wp is defined as
wp eij
  ¼
0 if Cov eij
   ¼ 0X
n∈N ;m∈M
Cov enmð Þj j
e Cov eijð Þj j
if Cov eij
   > 0
8><
>:
Where N, M are the number of rows and columns of
the expression matrix, respectively and |Cov(eij)| is the
number of previous biclusters containing eij. The use of
the penalty term biases the search against members
which already have appeared in the previous biclusters,
thus reducing the overlapping amongst the biclusters.
wd is defined as wr• δrowB þ wc• δcolumnB
 
and δ is the
threshold mean squared residue and biclusters with
mean squared residue above δ are discarded.
Solution procedure
The current optimization formulation has been identi-
fied to be NP-hard and has been shown to be effect-
ively handled by evolutionary techniques like Genetic
Algorithm (GA) [15]. GA is an iterative search process
which looks for the fittest member of a population
(candidate solutions) using the biological principle of
evolution under mutation and natural selection [44].
In a typical GA, the optimization variables are encoded
as a sequence of binary bits and these sequences are
concatenated to form the chromosome. Thus, for the
present formulation, each chromosome consists of I
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forming the I + J binary bits of the chromosome. The
binary variables, 0 and 1 represent the absence or
presence of a gene (or condition) respectively. Thus, a
GA population is made of chromosomes with each
chromosome representing a candidate bicluster.
Each chromosome has a metric associated with it
called the fitness which we wish to maximize. The GA
algorithm is initiated by randomly initializing a popula-
tion of chromosomes (i.e. biclusters). The population is
continuously evolved in every generation by the opera-
tors: reproduction, crossover and mutation. At the end
of every generation, individuals for the next one are
selected on the basis of their fitness values. This cycle of
evolution is continued until a predetermined termin-
ation criterion is reached. For the present case, we con-
tinued the simulations for a maximum number of
generations until no further change in the population
was observed. The biclustering formulation was coded
in FORTRAN R90 and the Genetic Algorithm (version
1.7a) driver obtained from David Carroll, CU Aerospace,
Urbana, IL. Computations were performed on INTEL
(R) Core (TM) 2 Quad CPU (Q8400 @ 2.66 GHz).
Determination of robust biclusters
The inherent noise in biological systems makes it diffi-
cult to draw meaningful conclusions from a determinis-
tic analysis. The formulation proposed above is based on
the mean gene expression data which possibly reduces
confidence in the identified bicluster. Here we have
adopted the bootstrap technique to obtain robust biclus-
ters from noisy experimental data. Bootstrap is a statis-
tical technique to generate large data set from a small
number of experimental replicates, using sampling with
replacement technique. The present formulation system-
atically re-samples the original experimental data set
using Monte Carlo algorithm to generate the artificial
data set. The optimization formulation of the bicluster-
ing problem is then solved at each of the bootstrap data
points to generate a family of alternate biclusters. The
final goal will be to identify the most repeated biclusters
in the entire array, based on the justification that such a
bicluster will be relatively insensitive to experimental
noise and hence is robust. To this end, the number of
repeats of a particular gene-condition combination is
analyzed using the quicksort algorithm (N log N). Our
analysis showed that the complete bicluster was typically
not repeated significantly; instead only subsets of the
biclusters were repeated sufficient number of times. For
identification of robust biclusters, we set the threshold
frequency of repeats as 500 out of every 1000 alternate
biclusters. The most repeated subsets are thereby con-
cluded to be robust under experimental noise. The work
flow for the entire analysis is depicted in Figure 1.Additional files
Additional file 1: Principal Component Analysis.docx
Additional file 2: Selection of biclustering parameters.docx
Additional file 3: Transcription factors and primers list.docx
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed experiments: IB MJ ASG SM. Performed the
experiments: MJ. Conducted mathematical analysis: SM, XZ, LZ. Contributed
materials/analysis tools: IB. Drafted the manuscript: SM IB. All authors read
and approved the final manuscript.
Acknowledgements
We would like to thank Dr. Ira Fox from the University of Pittsburgh for his
generous gift of H1 hESCs.
Author details
1Department of Chemical and Petroleum Engineering, University of
Pittsburgh, 1249 Benedum Hall, 3700 O’Hara Street, Pittsburgh, PA 15261,
USA. 2Department of Bioengineering, University of Pittsburgh, 360B CNBIO,
300 Technology Drive, Pittsburgh, PA 15219, USA. 3School of Mathematics
and Statistics, Central China Normal University, Wuhan, China. 4Department
of Pathology, University of Pittsburgh, Pittsburgh, PA, USA. 5McGowan
Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA,
USA. 6Thomas E. Starzl Transplantation Institute, University of Pittsburgh,
Pittsburgh, PA, USA. 7Center for Innovative Regenerative Therapies,
Department of Surgery, Transplantation Section of Children's Hospital of
Pittsburgh, Pittsburgh, PA, USA.
Received: 13 August 2012 Accepted: 11 December 2012
Published: 15 December 2012
References
1. Zhang DH, Jiang W, Shi Y, Deng HK: Generation of pancreatic islet cells
from human embryonic stem cells. Sci China Series C: Life Sci 2009,
52:615–621.
2. D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE: Efficient
differentiation of human embryonic stem cells to definitive endoderm.
Nat Biotechnol 2005, 23:1534–1541.
3. D’Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman
MA, Kroon E, Carpenter MK, Baetge EE: Production of pancreatic
hormone–expressing endocrine cells from human embryonic stem cells.
Nat Biotechnol 2006, 24:1392–1401.
4. Payne C, King J, Hay D: The role of activin/nodal and Wnt signaling in
endoderm formation. Activins Inhibins 2011, 85:207.
5. Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H: Highly
efficient differentiation of human ES cells and iPS cells into mature
pancreatic insulin-producing cells. Cell res 2009, 19:429–438.
6. Phillips BW, Hentze H, Rust WL, Chen QP, Chipperfield H, Tan EK, Abraham
S, Sadasivam A, Soong PL, Wang ST: Directed differentiation of human
embryonic stem cells into the pancreatic endocrine lineage. Stem cells
develop 2007, 16:561–578.
7. Basma H, Soto-Gutiérrez A, Yannam GR, Liu L, Ito R, Yamamoto T, Ellis E,
Carson SD, Sato S, Chen Y: Differentiation and transplantation of human
embryonic stem cell-derived hepatocytes. Gastroenterology 2009,
136:990–999. e994.
8. Friedman J, Hastie T, Tibshirani R: The elements of statistical learning.:
Springer Series in Statistics: Springer Verlag; 2008.
9. Slonim DK: From patterns to pathways: gene expression data analysis
comes of age. Nat Genet 2002, 32:502–508.
10. Kerr G, Ruskin HJ, Crane M, Doolan P: Techniques for clustering gene
expression data. Comp biol med 2008, 38:283–293.
11. Cheng Y, Church GM: Biclustering of expression data. Molecular Biology: In
Proceedings of International Conference on Intelligent Systems in; 2000:93.
12. Yang J, Wang H, Wang W, Yu P: Enhanced biclustering on expression
data. Proc Third IEEE Symp Bioinformatics Bioeng 2003, :321–327.
Mathew et al. BMC Systems Biology 2012, 6:154 Page 13 of 13
http://www.biomedcentral.com/1752-0509/6/15413. Madeira SC, Oliveira AL: Biclustering algorithms for biological data
analysis: a survey. IEEE Trans comput Biol Bioinformatics 2004, 1:24–45.
14. Bleuler S, Prelic A, Zitzler E: An EA framework for biclustering of gene
expression data. Evol Comput 2004, 161:166–173. 2004 CEC2004 Congress
on; 19–23 June 2004.
15. Divina F, Aguilar-Ruiz JS: Biclustering of expression data with evolutionary
computation. Knowl Data Eng, IEEE Trans 2006, 18:590–602.
16. Willems E, Leyns L, Vandesompele J: Standardization of real-time PCR
gene expression data from independent biological replicates. Anal
Biochem 2008, 379:127–129.
17. Efron B, Tibshirani R: An introduction to the bootstrap.: Chapman & Hall/CRC
Press; 1993.
18. Politis DN, Romano JP: The stationary bootstrap. J Am Stat Assoc 1994,
89:1303–1313.
19. Hanczar B, Nadif M: Using the bagging approach for biclustering of gene
expression data. Neurocomputing 2011, 74:1595–1605.
20. Bernardo AS, Faial T, Gardner L, Niakan KK, Ortmann D, Senner CE, Callery
EM: BRACHYURY and CDX2 mediate BMP-induced differentiation of
human and mouse pluripotent stem cells into embryonic and
extraembryonic lineages. Cell stem cell 2011, 9:144–155.
21. Xu X, Browning V, Odorico J: Activin, BMP and FGF pathways cooperate
to promote endoderm and pancreatic lineage cell differentiation from
human embryonic stem cells. Mech Dev 2011, 128:412–427.
22. Yu P, Pan G, Yu J, Thomson JA: FGF2 Sustains NANOG and Switches the
Outcome of BMP4-Induced Human Embryonic Stem Cell Differentiation.
Cell stem cell 2011, 8:326–334.
23. Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, Menendez
L, Kulik M, Dalton S: Signaling Network Crosstalk in Human Pluripotent
Cells: A Smad2/3-Regulated Switch that Controls the Balance between
Self-Renewal and Differentiation. Cell stem cell 2012, 10:312–326.
24. McLean AB, D’Amour KA, Jones KL, Krishnamoorthy M, Kulik MJ, Reynolds
DM, Sheppard AM, Liu H, Xu Y, Baetge EE: Activin a efficiently specifies
definitive endoderm from human embryonic stem cells only when
phosphatidylinositol 3 kinase signaling is suppressed. Stem Cells 2007,
25:29–38.
25. Reynolds D, Vallier L, Chng Z, Pedersen R: Signaling Pathways in
Embryonic Stem Cells. In Regulatory Networks in Stem Cells. Edited by
Rajashekhar VK, Vemuri MK. New York NY: Human Press; 2009:293–308.
26. Shiraki N, Yoshida T, Araki K, Umezawa A, Higuchi Y, Goto H, Kume K, Kume
S: Guided Differentiation of Embryonic Stem Cells into Pdx1 Expressing
Regional Specific Definitive Endoderm. Stem Cells 2008, 26:874–885.
27. Mitra S, Banka H, Paik JH: Evolutionary fuzzy biclustering of gene
expression data. Lecture notes in Computer Science 2007, 4481:284–291.
28. Filippone M, Masulli F, Rovetta S, Mitra S, Banka H: Possibilistic approach to
biclustering: An application to oligonucleotide microarray data analysis.
Lecture notes in Computer Science 2006, 4210:312–322.
29. Nosova E, Tagliaferri R, Masulli F, Rovetta S: Biclustering by Resampling.
Comput Int Methods Bioinformatics Biostatistics 2011, :147–158.
30. Zorn AM, Wells JM: Vertebrate endoderm development and organ
formation. Annual rev cell dev biol 2009, 25:221.
31. Zaret KS, Grompe M: Generation and regeneration of cells of the liver
and pancreas. Science’s STKE 2008, 322:1490.
32. Katoh M: CER1 is a common target of WNT and NODAL signaling
pathways in human embryonic stem cells. Int j mol med 2006,
17:795–799.
33. Mfopou JK, Chen B, Sui L, Sermon K, Bouwens L: Recent advances and
prospects in the differentiation of pancreatic cells from human
embryonic stem cells. Diabetes 2010, 59:2094–2101.
34. Poulain M, Fürthauer M, Thisse B, Thisse C, Lepage T: Zebrafish endoderm
formation is regulated by combinatorial Nodal, FGF and BMP signalling.
Development 2006, 133:2189.
35. Sulzbacher S, Schroeder IS, Truong TT, Wobus AM: Activin A-Induced
Differentiation of Embryonic Stem Cells into Endoderm and Pancreatic
Progenitors—The Influence of Differentiation Factors and Culture
Conditions. Stem Cell Rev Reports 2009, 5:159–173.
36. Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H: Defining early lineage
specification of human embryonic stem cells by the orchestrated
balance of canonical Wnt/-catenin, Activin/Nodal and BMP signaling.
Development 2008, 135:2969.37. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, Thomson JA:
BMP4 initiates human embryonic stem cell differentiation to
trophoblast. Nat Biotechnol 2002, 20:1261–1264.
38. Vallier L, Touboul T, Chng Z, Brimpari M, Hannan N, Millan E, Smithers LE,
Trotter M, Rugg-Gunn P, Weber A: Early cell fate decisions of human
embryonic stem cells and mouse epiblast stem cells are controlled by
the same signalling pathways. PLoS One 2009, 4:e6082.
39. Katoh M: Review Cross-talk of WNT and FGF Signaling Pathways at
GSK3β to Regulate β-Catenin and SNAIL Signaling Cascades. Cancer biol
therapy 2006, 5:1059–1064.
40. Wilding L, Gannon M: The role of pdx1 and HNF6 in proliferation and
differentiation of endocrine precursors. Diabetes/metabol res rev 2004,
20:114–123.
41. Voskas D, Ling LS, Woodgett JR: Does GSK-3 provide a shortcut for PI3K
activation of Wnt signalling? F1000 biol reports 2010, 2:82.
42. Nostro MC, Sarangi F, Ogawa S, Holtzinger A, Corneo B, Li X, Micallef SJ,
Park IH, Basford C, Wheeler MB: Stage-specific signaling through TGFβ
family members and WNT regulates patterning and pancreatic
specification of human pluripotent stem cells. Development 2011,
138:861–871.
43. Tanay A, Sharan R, Shamir R: Biclustering algorithms: A survey. In
Handbook of comput mol biol. Edited by Aluru S. Chapman and Hall/CRC:;
2005.
44. Goldberg DE: Genetic algorithms in search, optimization, and machine
learning.: Addison Wesley Publishing House; 1989.
doi:10.1186/1752-0509-6-154
Cite this article as: Mathew et al.: Analysis of alternative signaling
pathways of endoderm induction of human embryonic stem cells
identifies context specific differences. BMC Systems Biology 2012 6:154.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
